Fig. 2From: Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy eraKaplan Meyer curves. No statistically significant differences between the EXTREME and PTC schedule subgroups were reported, in terms of OS in our patient population (p value 0.400)Back to article page